Trade TXG stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
10x Genomics, Inc. Class A (TXG) is trading at US$76.60, down 0.48% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$8.48B. Over the past 52 weeks, TXG has traded between US$11.16 and US$79.94. On Syfe you can trade TXG with $0 commission and add it to your watchlist.
| Previous close | US$76.97 |
|---|---|
| Market cap | US$8.48B |
| 52-week range | US$11.16 – US$79.94 |
| Volume | 2.88M |
| Exchange | US |
Add to Watchlist
Set Price Alert
10x Genomics, Inc. Class A
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Year: 2019
10x Genomics, Inc. Class A (TXG) stock is trading at US$76.60, -0.48% from the previous close of US$76.97.
The market cap for 10x Genomics, Inc. Class A (TXG) stock is approximately US$8.48B.
The 52-week high for 10x Genomics, Inc. Class A (TXG) stock is US$79.94.
The 52-week low for 10x Genomics, Inc. Class A (TXG) stock is US$11.16.
10x Genomics, Inc. Class A (TXG) does not currently pay a dividend.
Stay on top of TXG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
